Logo
Subscribe Now

All Posts by Date

B-MoGen Biotechnologies and CytoSen Therapeutics Sign an Agreement for the Development of Gene-Modified Therapies

B-MoGen Biotechnologies and CytoSen Therapeutics Sign an Agreement for the Development of Gene-Modified Therapies

Athersys Reports Results of Multistem Cell Therapy (IV) in Patients with Acute Respiratory Distress Syndrome (ARDS)

Athersys Reports Results of Multistem Cell Therapy (IV) in Patients with Acute Respiratory Distress Syndrome (ARDS)

Grifols Signs a License and Commercialization Agreement with Rigel Pharmaceuticals for Fostamatinib

Grifols Signs a License and Commercialization Agreement with Rigel Pharmaceuticals for Fostamatinib

23andMe's MAP Report Receives FDA's 510(k) Clearance for Hereditary Colorectal Cancers

23andMe's MAP Report Receives FDA's 510(k) Clearance for Hereditary Colorectal Cancers

Philogen Collaborates with Johnson&Johnson (J&J)- Novartis and Celgene

Philogen Collaborates with Johnson&Johnson (J&J)- Novartis and Celgene

Amgen's Repatha (evolocumab) Receives NMPA (CFDA) Approval for Reduction of Cardiovascular Risks in China

Amgen's Repatha (evolocumab) Receives NMPA (CFDA) Approval for Reduction of Cardiovascular Risks in China

Image

Stay Connected

We Have a Viewership of 1,00,000 + Views

Join the PharmaShot Family

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2021 PharmaShots - All Rights Reserved.